|Purity:||99%||Shipment:||FedEx, EMS, HKEMS, TNT, DHL, UPS|
sarms bodybuilding supplements
YK11 SARMS Anabolic Steroids Bodybuilding Weight Loss For Faster Muscle Gaining
|Synonym||(17-alpha,20E) 17,20-[(1-methoxyethylidene)bis(oxy)] 3-oxo-19-norpregna-4,20-diene 21-carboxylic acid methyl ester|
|Appearance||White crystalline powder|
|Packing||1kg net/foil bag, 5kg/drum.|
|Storage||Shading , Confined Preservation|
|Usage||Fat loss; muscle growth|
YK11 actually increases the ability to generate muscle so is often used within a bulking cycle but it can also help during cutting too. This is because it will only add lean mass, and not just bulk. Therefore, it can prevent the loss of muscle which can occur when calorific intake is slashed making it ideal for cutting cycles.
Although still in its infancy, the potential uses for YK11 on a bulking cycle are almost limitless. Early indications suggest that this could be the strongest SARMs to hit the market providing the greatest potential for adding sheer muscle.
The compound works by inhibiting the action of myostatin on the muscle which in turn allows for far superior muscle growth.
|Description||White Or Almost White Crystalline Powder||White Crystalline Powder|
|Loss On Drying||≤0.5%||0.20%|
|Residue On Ignition||≤0.1%||0.02%|
|Conclusion||Be Conform With Enterprise Standard|
Recommended maximum dose YK11 is require dosages of 2.0-5.0mg b.i.d. in males and 0.5mg-2mg b.i.d. in females to achieve optimal effects.
|RAD140||1182367-47-0||New generation for gaining mass and cutting edges|
|Andarine(S4)||401900-40-0||partial agonist, intended mainly for treatment of benign prostatic hypertrophy|
A growth hormone secretagogue, treatment of obesity,
a promising therapy for the treatment of frailty in the elderly
|LGD-4033||1165910-22-4||pharmacological profile similar to that of enobosarm, Ostarine,MK-2866|
|GW1516||317318-70-0||For obesity, diabetes, dyslipidemia and cardiovascular disease|
medical prescription for prevention of cachexia, atrophy,
and sarcopenia and for Hormone or Testoserone Replacement Therapy.
under development at The Scripps Research Institute (TSRI),
increases the level of metabolic activity in skeletal muscles of mice
acts by entering nucleoside pools,
significantly increasing levels of adenosine during periods of ATP breakdown
|YK11||431579-34-9||YK11: a SARM and myostatin inhibitor in one|
Contact Person: Mr. Jackson